title: Cardiovascular disease and bipolar disorder: risk and clinical implications.
authors.affiliation: Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, PA 15213, USA. swartzha@upmc.edu
authors.forename: Holly A
authors.initials: HA
authors.lastname: Swartz
authors.forename: Andrea
authors.initials: A
authors.lastname: Fagiolini
mesh_terms: D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D015992:Body Mass Index; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D002423:Cause of Death; D015897:Comorbidity; D003299:Cooperative Behavior; D006801:Humans; D033183:Interdisciplinary Communication; D018020:Lithium Compounds / Q000009:adverse effects / Q000627:therapeutic use; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000453:epidemiology / Q000401:mortality / Q000523:psychology; D009765:Obesity / Q000175:diagnosis / Q000453:epidemiology / Q000401:mortality; D010348:Patient Care Team; D011379:Prognosis; D012008:Recurrence; D012307:Risk Factors; D059020:Suicidal Ideation; D014635:Valproic Acid / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D014635:Valproic Acid